The project aims to identify and better understand the epigenomic contributions to schizophrenia and substance use disorders, and predict response to treatment. Data from large-scale methylome-wide association studies and phase III clinical trials are available to achieve this goal.
The project is highly multidisciplinary and interactive involving external collaborators in the US and abroad (e.g., Karolinska Institute Sweden). The Center is well funded and equipped, occupying a suite of state-of-the-art laboratories on the university’s medical campus. The position is initially for two years and offers ample opportunities for publishing articles and career development.
The successful candidate will have a PhD (or equivalent degree) in psychiatry/psychology/epidemiology or statistics/computational biology. S/he will analyze high dimensional datasets that for an important part are generated (in-house) using next-generation sequencing of genomes, methylomes, and transcriptomes. Experience with Linux/Unix and R is desirable.
All interested applicants should email a current resume and three (3) names and contact information of references to: Edwin van den Oord (email@example.com) or Karolina Aberg (firstname.lastname@example.org) at Virginia Commonwealth University, Center for Biomarker Research and Precision Medicine.
Virginia Commonwealth University is an Equal Opportunity / Affirmative Action Employer. Women, minorities, and persons with disabilities are encouraged to apply.